The MYC oncogene has been widely recognized as a master regulator implicated in numerous hallmarks of cancer, including uncontrolled proliferation, sustained tumor growth, metastasis, immune evasion, and therapy resistance (Papadimitropoulou et al., 2024; Whitfield and Soucek, 2025; Jha et al., 2023). This evidence concerns the gene MYC and neoplasm.